Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. (Q47944462)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

adaptive radiation therapy

12 November 2019

main subject

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

S A Leibel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

P B Gaudin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

G J Kutcher

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

N E Fleshner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

E S Venkatramen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

V E Reuter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

W R Fair

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C C Ling

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Z Fuks

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

491-500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

Analysis of Risk Factors Associated with Prostate Cancer Extension to the Surgical Margin and Pelvic Node Metastasis at Radical Prostatectomy

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Role of Nerve-Sparing Radical Prostatectomy for Clinical Stage B2 Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Resection margin status in radical retropubic prostatectomy specimens: relationship to type of operation, tumor size, tumor grade and local tumor extension

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Impact of Radical Prostatectomy in the Management of Clinically Localized Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Positive surgical margins at radical prostatectomy: importance of the apical dissection.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Positive margins after radical prostatectomy: correlation with local recurrence and distant progression

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Radical prostatectomy. Patterns of local failure and survival in 67 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Radical Surgery for Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Prostate carcinoma: radiation treatment of the primary and regional lymphatics

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

External beam radiotherapy for adenocarcinoma of the prostate: a clinical followup

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Radiation therapy in the definitive treatment of localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Biopsy-proved tumor following definitive irradiation for resectable carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Potential benefit of improved local tumor control in patients with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Prognostic significance of pelvic recurrence and distant metastasis in prostate carcinoma following definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Boost treatment of the prostate using shaped, fixed fields

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Conventional external beam radiation therapy for prostatic cancer: where do we go from here?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Inter-tumor heterogeneity and radiation dose-control curves

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Cox's Regression Model for Counting Processes: A Large Sample Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Is the steepness of dose-incidence curves for tumour control or complications due to variation before, or as a result of, irradiation?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

The relation between tumour lethal doses and the radiosensitivity of tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

The statistics of dose/cure relationships for irradiated tumours. Part II

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

The Value of Serial Prostate Specific Antigen Determinations 5 Years after Radiotherapy: Steeply Increasing Values Characterize 80% of Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Results of 3D conformal radiotherapy in the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Radiobiological considerations in the design of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

An approach to the interpretation of clinical data on the tumour control probability-dose relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900091-1

7 January 2021

10.1016/S0360-3016(98)00091-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635694%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference